Education
About Us
Working with TipRanks
Follow Us
Collegium Pharmaceutical (COLL)
NASDAQ:COLL
Total Valuation
Collegium Pharmaceutical has a market cap or net worth of $845.07M. The enterprise value is $1.94B.
Market Cap$845.07M
Enterprise Value$1.94B
Share Statistics
Collegium Pharmaceutical has 32.13M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32.13M
Owned by Insiders4.44%
Owned by Instutions0.90%
Financial Efficiency
Collegium Pharmaceutical’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is 9.78%.
Return on Equity (ROE)30.23%
Return on Assets (ROA)4.16%
Return on Invested Capital (ROIC)9.78%
Return on Capital Employed (ROCE)14.72%
Revenue Per Employee$1,768,764.706
Profits Per Employee$193,809.524
Employee Count357
Asset Turnover0.38
Inventory Turnover7.15
Valuation Ratios
The current PE Ratio of Collegium Pharmaceutical is 13.36. Collegium Pharmaceutical’s PEG ratio is 0.40.
PE Ratio13.36
PS Ratio1.46
PB Ratio4.04
Price to Fair Value4.04
Price to FCF4.55
Price to Operating Cash Flow4.51
PEG Ratio0.40
Income Statement
In the last 12 months, Collegium Pharmaceutical had revenue of $631.45M and earned $69.19M in profits. Earnings per share was $2.18.
Revenue$631.45M
Gross Profit$377.34M
Operating Income$169.90M
Pretax Income$98.57M
Net Income$69.19M
EBITDA283.38M
Earnings Per Share (EPS)2.18
Cash Flow
In the last 12 months, operating cash flow was $204.98M and capital expenditures -$1.65M, giving a free cash flow of $203.33M billion.
Operating Cash Flow$204.98M
Free Cash Flow$203.33M
Free Cash Flow per Share$6.33
Dividends & Yields
Collegium Pharmaceutical pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield21.99%
Earnings Yield7.48%
Stock Price Statistics
Beta0.23
52-Week Price Change-25.16%
50-Day Moving Average29.39
200-Day Moving Average32.88
Relative Strength Index (RSI)38.82
Average Volume (3m)464.60K
Important Dates
Collegium Pharmaceutical upcoming earnings date is May 8, 2025, TBA.
Last Earnings DateFeb 27, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Collegium Pharmaceutical as a current ratio of 0.95, with Debt / Equity ratio of 3.75
Current Ratio0.95
Quick Ratio0.88
Debt to Market Cap0.93
Net Debt to EBITDA4.64
Interest Coverage Ratio2.30
Taxes
In the past 12 months, Collegium Pharmaceutical has paid $29.38M in taxes.
Income Tax$29.38M
Effective Tax Rate29.80%
Enterprise Valuation
Collegium Pharmaceutical EV to EBITDA ratio is 10.08, with an EV/FCF ratio of 8.43.
EV to Sales2.71
EV to EBITDA10.08
EV to Free Cash Flow8.43
EV to Operating Cash Flow8.36
Balance Sheet
Collegium Pharmaceutical has $162.76M in cash and marketable securities with $237.17M in debt, giving a net cash position of $74.41M billion.
Cash & Marketable Securities$162.76M
Total Debt$237.17M
Net Cash$74.41M
Net Cash Per Share$2.32
Tangible Book Value Per Share-$25.56
Margins
Gross margin is 59.76%, with operating margin of 26.91%, and net profit margin of 10.96%.
Gross Margin59.76%
Operating Margin26.91%
Pretax Margin15.61%
Net Profit Margin10.96%
EBITDA Margin26.91%
EBIT Margin27.32%
Analyst Forecast
The average price target for Collegium Pharmaceutical is $43.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$43.00
Price Target Upside63.50%
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast11.41%
EPS Growth Forecast45.89%